Drug
Pegtibatinase
Pegtibatinase: highest development phase Phase 3, developed by Travere Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Travere Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pegtibatinase NCT06431893 | Phase 3 | Homocystinuria |
Latest
No recent events.
Follow Pegtibatinase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.